Medtronic PLC 2023 SR
The report highlights Medtronic's progress in FY23, focusing on its mission to alleviate pain, restore health, and extend life. Key achievements include a 35% reduction in operational greenhouse gas emissions intensity and a 17% reduction in waste intensity compared to the FY20 baseline. The company committed to setting science-based targets through the SBTi and achieved 100% gender and ethnically diverse pay equity in the U.S. for the third consecutive year. Medtronic served over 74 million patients and invested $2.7 billion in R&D, while also advancing inclusion with 43% of global manager roles held by women.
Company: Medtronic PLC
Sector: Manufacturing
Country: Ireland
Year: 2023
Type: SR
Pages: 142
Medtronic PLC
The report highlights Medtronic's progress in FY23, focusing on its mission to alleviate pain, restore health, and extend life. Key achievements include a 35% reduction in operational greenhouse gas emissions intensity and a 17% reduction in waste intensity compared to the FY20 baseline. The company committed to setting science-based targets through the SBTi and achieved 100% gender and ethnically diverse pay equity in the U.S. for the third consecutive year. Medtronic served over 74 million patients and invested $2.7 billion in R&D, while also advancing inclusion with 43% of global manager roles held by women.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Apr 30, 2022 - Apr 28, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees